Department of Anesthesiology, EENT Hospital, Shanghai, 200031, China.
Can J Anaesth. 2013 Apr;60(4):385-92. doi: 10.1007/s12630-013-9886-x. Epub 2013 Jan 24.
Children undergoing strabismus surgery under sevoflurane anesthesia often experience emergence agitation (EA) and postoperative vomiting (POV). This study compared the effects of intraoperative dexmedetomidine, ketamine, and placebo on postoperative EA and POV.
Eighty-four children (aged two to seven years) undergoing elective strabismus surgery under sevoflurane anesthesia were randomly assigned to one of three groups (n = 28 each). Intraoperatively, the placebo, dexmedetomidine, and ketamine groups received normal saline, dexmedetomidine 1 μg·kg(-1) iv plus a 1 μg·kg(-1)·hr(-1) infusion, and ketamine 1 mg·kg(-1) iv plus a 1 mg·kg(-1)·hr(-1) infusion, respectively. Agitation scores (Pediatric Anesthesia Emergence Delirium [PAED] scale) and POV were assessed in the postanesthetic care unit (PACU) and for 24 hr on the ward. Pain scores and times to laryngeal mask airway (LMA™) removal, resumption of mental orientation, and discharge from the PACU were also assessed.
Seventy-eight children completed the study. Peak PAED scores for EA were lower in the dexmedetomidine (P < 0.001) and ketamine (P = 0.002) groups than in the placebo group. Incidence of POV was lower in the dexmedetomidine group (15%) than in the ketamine (44%; P = 0.02) or placebo (45.8%; P = 0.02) groups. Pain scores on the ward were lower in the dexmedetomidine (P < 0.001) and ketamine (P < 0.001) groups than in the placebo group. Time to LMA removal was similar in all groups. Time for resumption of mental orientation and time to discharge from PACU were longer in the dexmedetomidine and ketamine groups than in the placebo group.
Dexmedetomidine and ketamine appear to prevent postoperative agitation and pain after sevoflurane anesthesia for pediatric strabismus surgery. Dexmedetomidine also prevents POV.
在七氟醚麻醉下接受斜视手术的儿童常经历术后躁动(EA)和术后呕吐(POV)。本研究比较了术中给予右美托咪定、氯胺酮和安慰剂对术后 EA 和 POV 的影响。
84 名(2 至 7 岁)接受七氟醚麻醉下择期斜视手术的儿童被随机分为三组(每组 28 例)。术中,安慰剂组、右美托咪定组和氯胺酮组分别接受生理盐水、右美托咪定 1μg·kg(-1)静脉注射加 1μg·kg(-1)·hr(-1)输注、氯胺酮 1mg·kg(-1)静脉注射加 1mg·kg(-1)·hr(-1)输注。在麻醉后恢复室(PACU)和病房内的 24 小时内评估躁动评分(小儿麻醉苏醒期躁动量表[PAED])和 POV。还评估了疼痛评分以及喉罩(LMA™)取出、恢复精神定向和 PACU 出院的时间。
78 名儿童完成了研究。EA 时的峰值 PAED 评分在右美托咪定组(P < 0.001)和氯胺酮组(P = 0.002)均低于安慰剂组。右美托咪定组(15%)的 POV 发生率低于氯胺酮组(44%;P = 0.02)或安慰剂组(45.8%;P = 0.02)。病房内的疼痛评分在右美托咪定组(P < 0.001)和氯胺酮组(P < 0.001)均低于安慰剂组。各组间 LMA 取出时间相似。右美托咪定组和氯胺酮组恢复精神定向的时间和 PACU 出院时间均长于安慰剂组。
右美托咪定和氯胺酮似乎可预防七氟醚麻醉下小儿斜视手术后的躁动和疼痛。右美托咪定还可预防 POV。